The Journal of Clinical Psychiatry

Page 270

More JCP Articles

Educational Activity

Risks and Benefits of Available Treatments for Adult ADHD

March 15, 2011

Jeffrey H. Newcorn

Educational Activity

Transitioning From Acute to Long-Term Treatment in Schizophrenia

March 15, 2011

John M. Kane

Educational Activity

Crisis of Confidence: Antidepressant Risk Versus Benefit

March 15, 2011

Andrew A. Nierenberg , Andrew C. Leon , Lawrence H. Price , et al

Original Research

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

March 8, 2011

Ofer Agid , Tamara Arenovich , Gautam Sajeev , et al

Original Research

Brief Behavioral Therapy for Refractory Insomnia in Residual Depression: An Assessor-Blind, Randomized Controlled Trial

March 8, 2011

Norio Watanabe , Toshi A. Furukawa , Shinji Shimodera , et al

Original Research

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

March 8, 2011

David E. Kemp , Ellyn Johnson , Wei V. Wang , et al

Article

Pregnancy as a Major Determinant for Discontinuation of Antidepressants: An Analysis of Data From The Health Improvement Network

March 8, 2011

Irene Petersen , Ruth E. Gilbert , Stephen J. W. Evans , et al

Article

QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone

March 8, 2011

Christoph U. Correll , Johnny D. Lops , Vicki Figen , et al

Review Article

Should We Expect "Neural Signatures" for DSM Diagnoses?

March 8, 2011

Seth J. Gillihan , Erik Parens

Original Research

Temporal Relationships Between Overweight and Obesity and DSM-IV Substance Use, Mood, and Anxiety Disorders: Results From a Prospective Study, the National Epidemiologic Survey on Alcohol and Related Conditions

March 8, 2011

Roger P. Pickering , RisÃ« B. Goldstein , Deborah S. Hasin , et al

Original Research

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

February 22, 2011

James G. Barbee , Thomas R. Thompson , Nowal J. Jamhour , et al

Original Research

Eszopiclone for PTSD & Insomnia Treatment

February 22, 2011

Read the full study on whether pharmacotherapy with eszopiclone improved short-term in PTSD severity and associated sleep disturbance

Mark H. Pollack , Elizabeth A. Hoge , John J. Worthington , et al

« 1 … 268 269 270 271 272 … 754 »

Risks and Benefits of Available Treatments for Adult ADHD

Transitioning From Acute to Long-Term Treatment in Schizophrenia

Crisis of Confidence: Antidepressant Risk Versus Benefit

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

Brief Behavioral Therapy for Refractory Insomnia in Residual Depression: An Assessor-Blind, Randomized Controlled Trial

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

Pregnancy as a Major Determinant for Discontinuation of Antidepressants: An Analysis of Data From The Health Improvement Network

QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone

Should We Expect "Neural Signatures" for DSM Diagnoses?

Temporal Relationships Between Overweight and Obesity and DSM-IV Substance Use, Mood, and Anxiety Disorders: Results From a Prospective Study, the National Epidemiologic Survey on Alcohol and Related Conditions

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Eszopiclone for PTSD & Insomnia Treatment

ELSEWHERE:

FOLLOW US:

More JCP Articles

Risks and Benefits of Available Treatments for Adult ADHD

Transitioning From Acute to Long-Term Treatment in Schizophrenia

Crisis of Confidence: Antidepressant Risk Versus Benefit

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

Brief Behavioral Therapy for Refractory Insomnia in Residual Depression: An Assessor-Blind, Randomized Controlled Trial

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

Pregnancy as a Major Determinant for Discontinuation of Antidepressants: An Analysis of Data From The Health Improvement Network

QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone

Should We Expect "Neural Signatures" for DSM Diagnoses?

Temporal Relationships Between Overweight and Obesity and DSM-IV Substance Use, Mood, and Anxiety Disorders: Results From a Prospective Study, the National Epidemiologic Survey on Alcohol and Related Conditions

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Eszopiclone for PTSD & Insomnia Treatment

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles